Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by VALEANT PHARMS NORTH

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
012093 New Drug Application Approval
017340 New Drug Application Approval New formulation (S) Standard review drug
018998 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019462 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019568 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
019931 New Drug Application Approval New formulation (S) Standard review drug
019963 New Drug Application Approval New formulation (S) Standard review drug
020401 New Drug Application Approval New formulation (S) Standard review drug
020648 New Drug Application Approval New formulation (S) Standard review drug (V) Orphan drug
020743 New Drug Application Approval New formulation (S) Standard review drug
020985 New Drug Application Approval New formulation (S) Standard review drug
021108 New Drug Application Approval New formulation (S) Standard review drug
021271 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
021894 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
022108 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
075116 Abbreviated New Drug Application Approval
075269 Abbreviated New Drug Application Approval
075289 Abbreviated New Drug Application Approval
076070 Abbreviated New Drug Application Approval
086101 Abbreviated New Drug Application Approval
089772 Abbreviated New Drug Application Approval
090071 Abbreviated New Drug Application Approval
090715 Abbreviated New Drug Application Approval

Back to Companies who have applied for FDA Drug Approval